December 20, 2024
(press release)
–
The passage of Cyclone Chido over the Mayotte archipelago on December 14 has been an unprecedented natural disaster. More than 100,000 people living in precarious housing have seen their homes completely destroyed. There is an urgent need to address essential requirements: water, food, debris clearance, and medical care. Given the scale of the disaster, the Fondation Pierre Fabre has decided to provide support amounting to €100,000 to address these urgent needs. These funds will be allocated to the French Red Cross, which is currently on-site and actively involved in emergency operations. Pierre Fabre Laboratories, of which the Fondation Pierre Fabre is the majority shareholder, will also donate hygiene kits to the affected residents. About Pierre Fabre Fondation Recognized as a public utility since 1999, the Pierre Fabre Foundation works to provide better access to medicines and quality healthcare for populations in the Global South. Presse Contacts Guillaume Festivi – Responsible of communication – +33 (0) 6 20 88 61 55
The Fondation Pierre Fabre remains attentive to the evolving situation and expresses its solidarity with all the victims of this tragic event.
Its five areas of intervention are the training of pharmacists and healthcare professionals; the fight against sickle cell disease; access to care for vulnerable populations; e-health; and dermatology, particularly for people with albinism. In 2024, the Foundation is conducting more than 30 programs in 21 countries across Africa, Southeast Asia, Lebanon, and Haiti.
The Pierre Fabre Foundation is the majority shareholder of Pierre Fabre Laboratories, holding 86% of the shares.
This organization, unique in France at this level of commitment, helps to preserve the independence of the group and provides the Foundation with sustainable means to fund its activities.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
